ARS Pharmaceuticals, Inc. vs NEKTAR THERAPEUTICS, risk disclosures compared

5topics both disclose

5only ARS Pharmaceuticals, Inc.

2only NEKTAR THERAPEUTICS

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	ARS Pharmaceuticals, Inc.	NEKTAR THERAPEUTICS
Ransomware	21	1
Enforcement Action	3	5
Internal Control	3	4
Restatement	2	4
Material Weakness	2	1

Only ARS Pharmaceuticals, Inc.

Topic	Filings
Business Continuity	19
Cross Border Data Transfer	18
Privacy Compliance	8
Vendor Risk Management	3
Records Retention	1

Only NEKTAR THERAPEUTICS

Topic	Filings
AI Governance	2
Data Governance	2

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

ARS Pharmaceuticals, Inc. · NEKTAR THERAPEUTICS · All companies